Corey Goodman

Corey Goodman

Vermogen: 318 003 $ op 31-05-2026

74 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Corey S.
Goodman
was the founder of Exelixis, Inc. (1994), Second Genome, Inc. (2009), Labrys Biologics, Inc. (2012) where served as Chairman from 2012 to 2014, Axonis Therapeutics, Inc. (2008) where served as Executive Chairman since 2008, venBio Partners LLC (2009) where served as Managing Partner, Avoro Capital Advisor LLC (2009) where served as Managing Partner, Renovis, Inc. (2001) where served as President, Chief Executive Officer & Director from 2001 to 2007, and Ossianix, Inc. (2011) where served as Chairman.
Dr. Goodman is also the founder of The Helen Wills Neuroscience Institute,Tallac Therapeutics, Inc...- Current jobs include Executive Chairman at ALX Oncology Holdings, Inc. since 2015; Director at Bay Area Science & Innovation Consortium, Emaldi Corp., and Attralus, Inc.; Member of the National Academy of Sciences, American Academy of Arts & Sciences, American Philosophical Society, and The California Council on Science & Technology; Trustee of Goodman Barinaga Trust.
Former jobs include Executive Chairman, President & CEO of Solstice Biologics LLC from 2013 to 2014; Vice Chairman of The Bay Area Bioscience Association; Chairman of The National Research Council, iPierian, Inc., Heart Metabolics Ltd., and Kodiak Sciences, Inc.; Director at Limerick BioPharma, Inc. from 2007 to 2009, Mirna Therapeutics, Inc., NeuroTherapeutics Pharma, Inc., Checkmate Pharmaceuticals, Inc. from 2015 to 2020, and Parabilis Medicines, Inc.; SVP, President-Biotherapeutics & Bioinnovation at Pfizer Inc. from 2007 to 2009; Professor at Stanford University; Member-Supervisory Board at Evotec SE in 2010; Professor at the University of California, Berkeley from 1987 to 2001; Vice President of The McKnight Endowment Fund for Neuroscience.
Education includes undergraduate degree from Stanford University and doctorate from the University of California, Berkeley.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
31-03-2026 167.370 ( 0,12% ) 318 003 $ 31-05-2026

Actieve functies van Corey Goodman

BedrijvenFunctieBegin
ALX ONCOLOGY HOLDINGS INC. Voorzitter 01-03-2015
Emaldi Corp.
Directeur/Bestuurslid -
Goodman Barinaga Trust
Directeur/Bestuurslid -
Oprichter -
Directeur/Bestuurslid -
Oprichter 01-01-2008
Oprichter 01-06-2009
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Eerdere bekende functies van Corey Goodman

BedrijvenFunctieEinde
░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Corey Goodman in detail bekijken

Opleiding van Corey Goodman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

91

Eerstegraads connecties

35

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit35

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Miscellaneous

Health Technology

Commercial Services

Bay Area Science & Innovation Consortium

Commercial Services

Health Technology

Finance

Health Technology

Health Technology

Finance

Health Technology

Health Technology

The Helen Wills Neuroscience Institute

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Emaldi Corp.

Goodman Barinaga Trust

Health Technology

Health Services

  1. Beurs
  2. Insiders
  3. Corey Goodman
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU